Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. Other stock markets 2026-07-03			5-day change	1st Jan Change
15.33 ^MXN	+0.66%		+2.47%	-14.31%

04-23	Genomma Lab Internacional, S.A.B. de C.V., Q1 2026 Earnings Call, Apr 23, 2026
04-23	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	14,951	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-14.44%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	18,812	18,414	17,284
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-15.42%	-2.12%	-6.14%
P/E	14.9x	12x	13.1x	11.7x	11.1x	6.98x	6.91x	5.53x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	1.06x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.2x	6.32x	0.2x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.82x	0.78x	0.72x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	1.03x	0.96x	0.83x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.4x	4.11x	3.52x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.8x	4.49x	3.85x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	8.46x	9.54x	7.7x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	11.8%	10.5%	13%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8013	1.098	1.5
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.23%	7.16%	9.78%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.195	2.219	2.77
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	36.5%	49.5%	54.2%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,323	19,238	20,830
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,280	4,485	4,903
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,923	4,105	4,493
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,137	2,251	2,646
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	3,862	3,464	2,334
Reference price ²	21.48	16.94	14.16	25.13	17.89	15.33	15.33	15.33
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,253	-	-
Announcement Date	2/23/22	2/22/23	2/21/24	2/26/25	2/25/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	6.98x	1.03x	4.4x	5.23%	855M
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	15.91x	6.08x	15.67x	2.65%	369.33B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%